Cargando…
Cardioprotective Mechanism of Leonurine against Myocardial Ischemia through a Liver–Cardiac Crosstalk Metabolomics Study
Leonurine has been shown to have excellent anti-myocardial ischemia effects. Our previous studies suggested that cardiac protection by leonurine during myocardial ischemia appeared to be inextricably linked to its regulation of the liver. At present, however, there are few mechanistic studies of leo...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599793/ https://www.ncbi.nlm.nih.gov/pubmed/36291721 http://dx.doi.org/10.3390/biom12101512 |
_version_ | 1784816680853045248 |
---|---|
author | Rong, Weiwei Li, Jiejia Pan, Dingyi Zhou, Qinbei Zhang, Yexuan Lu, Qianxing Wang, Liyun Wang, Andong Zhu, Yizhun Zhu, Qing |
author_facet | Rong, Weiwei Li, Jiejia Pan, Dingyi Zhou, Qinbei Zhang, Yexuan Lu, Qianxing Wang, Liyun Wang, Andong Zhu, Yizhun Zhu, Qing |
author_sort | Rong, Weiwei |
collection | PubMed |
description | Leonurine has been shown to have excellent anti-myocardial ischemia effects. Our previous studies suggested that cardiac protection by leonurine during myocardial ischemia appeared to be inextricably linked to its regulation of the liver. At present, however, there are few mechanistic studies of leonurine and its regulation of hepatic metabolism against ischemic injury. In this study, a metabolomics approach was developed to give a global view of the metabolic profiles of the heart and liver during myocardial ischemia. Principal component analysis and orthogonal partial least squares discrimination analysis were applied to filter differential metabolites, and a debiased sparse partial correlation analysis was used to analyze the correlation of the differential metabolites between heart and liver. As a result, a total of thirty-one differential metabolites were identified, six in the myocardial tissue and twenty-five in the hepatic tissue, involving multiple metabolic pathways including glycine, serine and threonine, purine, fatty acid, and amino acid metabolic pathways. Correlation analysis revealed a net of these differential metabolites, suggesting an interaction between hepatic and myocardial metabolism. These results suggest that leonurine may reduce myocardial injury during myocardial ischemia by regulating the metabolism of glycine, serine and threonine, purine, fatty acids, and amino acids in the liver and heart. |
format | Online Article Text |
id | pubmed-9599793 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95997932022-10-27 Cardioprotective Mechanism of Leonurine against Myocardial Ischemia through a Liver–Cardiac Crosstalk Metabolomics Study Rong, Weiwei Li, Jiejia Pan, Dingyi Zhou, Qinbei Zhang, Yexuan Lu, Qianxing Wang, Liyun Wang, Andong Zhu, Yizhun Zhu, Qing Biomolecules Article Leonurine has been shown to have excellent anti-myocardial ischemia effects. Our previous studies suggested that cardiac protection by leonurine during myocardial ischemia appeared to be inextricably linked to its regulation of the liver. At present, however, there are few mechanistic studies of leonurine and its regulation of hepatic metabolism against ischemic injury. In this study, a metabolomics approach was developed to give a global view of the metabolic profiles of the heart and liver during myocardial ischemia. Principal component analysis and orthogonal partial least squares discrimination analysis were applied to filter differential metabolites, and a debiased sparse partial correlation analysis was used to analyze the correlation of the differential metabolites between heart and liver. As a result, a total of thirty-one differential metabolites were identified, six in the myocardial tissue and twenty-five in the hepatic tissue, involving multiple metabolic pathways including glycine, serine and threonine, purine, fatty acid, and amino acid metabolic pathways. Correlation analysis revealed a net of these differential metabolites, suggesting an interaction between hepatic and myocardial metabolism. These results suggest that leonurine may reduce myocardial injury during myocardial ischemia by regulating the metabolism of glycine, serine and threonine, purine, fatty acids, and amino acids in the liver and heart. MDPI 2022-10-19 /pmc/articles/PMC9599793/ /pubmed/36291721 http://dx.doi.org/10.3390/biom12101512 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Rong, Weiwei Li, Jiejia Pan, Dingyi Zhou, Qinbei Zhang, Yexuan Lu, Qianxing Wang, Liyun Wang, Andong Zhu, Yizhun Zhu, Qing Cardioprotective Mechanism of Leonurine against Myocardial Ischemia through a Liver–Cardiac Crosstalk Metabolomics Study |
title | Cardioprotective Mechanism of Leonurine against Myocardial Ischemia through a Liver–Cardiac Crosstalk Metabolomics Study |
title_full | Cardioprotective Mechanism of Leonurine against Myocardial Ischemia through a Liver–Cardiac Crosstalk Metabolomics Study |
title_fullStr | Cardioprotective Mechanism of Leonurine against Myocardial Ischemia through a Liver–Cardiac Crosstalk Metabolomics Study |
title_full_unstemmed | Cardioprotective Mechanism of Leonurine against Myocardial Ischemia through a Liver–Cardiac Crosstalk Metabolomics Study |
title_short | Cardioprotective Mechanism of Leonurine against Myocardial Ischemia through a Liver–Cardiac Crosstalk Metabolomics Study |
title_sort | cardioprotective mechanism of leonurine against myocardial ischemia through a liver–cardiac crosstalk metabolomics study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599793/ https://www.ncbi.nlm.nih.gov/pubmed/36291721 http://dx.doi.org/10.3390/biom12101512 |
work_keys_str_mv | AT rongweiwei cardioprotectivemechanismofleonurineagainstmyocardialischemiathroughalivercardiaccrosstalkmetabolomicsstudy AT lijiejia cardioprotectivemechanismofleonurineagainstmyocardialischemiathroughalivercardiaccrosstalkmetabolomicsstudy AT pandingyi cardioprotectivemechanismofleonurineagainstmyocardialischemiathroughalivercardiaccrosstalkmetabolomicsstudy AT zhouqinbei cardioprotectivemechanismofleonurineagainstmyocardialischemiathroughalivercardiaccrosstalkmetabolomicsstudy AT zhangyexuan cardioprotectivemechanismofleonurineagainstmyocardialischemiathroughalivercardiaccrosstalkmetabolomicsstudy AT luqianxing cardioprotectivemechanismofleonurineagainstmyocardialischemiathroughalivercardiaccrosstalkmetabolomicsstudy AT wangliyun cardioprotectivemechanismofleonurineagainstmyocardialischemiathroughalivercardiaccrosstalkmetabolomicsstudy AT wangandong cardioprotectivemechanismofleonurineagainstmyocardialischemiathroughalivercardiaccrosstalkmetabolomicsstudy AT zhuyizhun cardioprotectivemechanismofleonurineagainstmyocardialischemiathroughalivercardiaccrosstalkmetabolomicsstudy AT zhuqing cardioprotectivemechanismofleonurineagainstmyocardialischemiathroughalivercardiaccrosstalkmetabolomicsstudy |